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The current study examined autobiographical memory and theory of mind (ToM), both of 
which are associated with overlapping subsystems in the default mode network, in a group of 
Parkinson’s disease (PD) patients who were characterised as not representing a stage of mild 
cognitive impairment, but at risk of future cognitive decline. The Autobiographical Memory 
Interview (AMI), which separately measures both personal episodic memory and personal 
semantic memory across the lifespan, was used for the first time in PD; a card sequencing 
task measured cognitive Theory of Mind (ToM) in these patients. Twenty non-MCI PD 
participants (18 above a threshold of 29% risk of future cognitive decline and 2 below this 
threshold) were compared with 15 healthy age and education matched controls (HC). PD 
participants showed significantly poorer personal episodic memory but unimpaired personal 
semantic memory, but neither measure was related to the cognitive risk score. Similarly their 
impaired ToM scores were unrelated to their risk scores. However, the Brief Visuospatial 
Memory Test showed a greater effect size than any other measures, and performance in the 
PD group was associated with the risk score, suggesting it may be a useful addition to 
improving a risk score in this patient group. Future research should examine these measures 
in larger sample sizes and in PD-MCI and PDD groups, and evaluate their MRI correlates. 
PD patients who do not meet criteria for PD-MCI nonetheless show a subtle range of 









1.1 Parkinson’s disease 
Parkinson’s disease (PD) is a progressive neurodegenerative condition causing significant 
motor and non-motor impairments, which eventuates in dementia (PDD) for over 80% of 
patients (Aarsland & Kurz, 2010a). The pre-requisite weakness of voluntary motor control in 
PD is associated with the loss of dopaminergic neurons projecting to the striatum (Jenkins et 
al., 1992) and functional disconnection in the striato-thalamo-frontal loop (Eimeren et al., 
2009). The core motor symptoms include resting tremor, bradykinesia, rigidity and postural 
instability resulting from reduced functional integrity of the prefrontal cortex. However, it is 
now widely recognised that a range of non-motor symptoms also characterise PD. These 
symptoms include mood disorders, depression, hallucinations, sleep disorders, sensory and 
autonomic dysfunction, behavioural disorders and especially cognitive dysfunction (Poewe, 
2008). In fact many non-motor symptoms may begin long before motor symptoms become 
evident, while new or worsening problems generally emerge throughout the disease course, 
significantly impacting quality of life. Dementia is associated with more rapid progression of 
the disease, reduced quality of life, increased care-giver burden and mortality (Aarsland & 
Kurz, 2010a). 
Braak staging provides a general model for progression in which cognitive decline is 
obvious at the last stages, 5 and 6, but some decline may begin as early as stage 2 (Figure 1, 
Hawkes et al., 2010). Clinical (motor) onset does not begin until stages 3 to 4. Cognitive 
decline in PD often leads to mild cognitive impairment (PD-MCI) (Dalrymple-Alford et al., 
2011; Litvan et al., 2011). PD-MCI patients are at high risk of PD with dementia (PDD) 











1.2 Mild cognitive impairment and pre-mild cognitive impairment  
Mild cognitive impairment (MCI) is cognitive decline that has not yet interfered significantly 
with daily life, but is greater than expected for the individual’s age and education level and 
often represents an intermediate stage prior to dementia (Gauthier et al., 2006). MCI is 
generally divided into two subgroups, amnesic MCI (aMCI) and non-amnesic MCI (nMCI). 
Amnesic MCI is the presence of memory impairment, whereas non-amnesic MCI is a non-
memory cognitive impairment (Peterson, 2004). The idea of MCI has now been adapted in 
the context of PD and about 25-30% of non-demented Parkinson’s patients have mild 
cognitive impairment (Litvan et al., 2011; Wood et al., 2016). Cognitive change associated 
with PD-MCI is significantly associated with older age at disease onset, longer disease 
duration, more severe motor symptoms, and advanced disease stage (Aarsland et al., 2010b). 
Early recognition of cognitive change is important if we are to attempt to intervene to 
improve outcomes and slow progression.  
Figure 1. Braak staging from symptom onset to end of disease (Hawkes, Tredici & Braak, 2010). 
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The novel concept of ‘pre-MCI’ has been introduced to define a risk of worsening 
cognition in the future. This term has mostly been used in Alzheimer’s research, and marks a 
transitory stage between normal cognition and MCI. In non-PD, pre-MCI patients have been 
shown to decline less than MCI patients but most eventually progress to Alzheimer’s (91% at 
autopsy within this cohort, Storandt et al., 2006).  Although the term ‘pre-MCI’ has not been 
used in PD research thus far, researchers are starting to examine the changes that occur 
between PD with normal cognition and PD-MCI. At baseline, Parkinson’s disease patients 
who had no cognitive impairment, but who later converted to MCI over 18 months, show 
bilateral temporal cortex thinning relative to the Parkinson’s disease with no cognitive 
impairment stable patients that did not progress (Mak et al., 2015). This suggests that there 
are physical changes in the brain prior to any overt cognitive changes. The value of a pre-
MCI status is that if an intervention can be administered at the earliest detection of cognitive 
change before progression to PD-MCI, then outcomes could be improved. 
This thesis investigated the differences between a non-MCI PD group, most of whom 
were at risk for future progression to MCI or dementia (i.e. pre-MCI), and healthy age-
matched controls. The current study focussed on autobiographical memory and theory of 
mind tasks (ToM). Performance on these tasks is influenced by frontal brain areas which are 
also implicated in Parkinson’s disease. Early stage PD patients show impairments in frontal 
lobe functions and atrophy in the left and right prefrontal cortex (Bruck, 2004). If 
autobiographical memory and ToM tasks show deficits in the non-MCI PD group compared 
to controls, then these tasks may provide suitable measures of future progression in PD. It 
was hypothesised that the non-MCI PD group will perform more poorly on a range of 
cognitive tasks than the control group, but most especially tasks that depend on the integrity 
of the frontal brain regions.  It was also hypothesised that there will be a correlation between 
performance on the theory of mind component of the card sequencing task and the 
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Autobiographical Memory Interview (AMI), as explained below. The primary novelty of this 
research was to examine the AMI (Kopelman, Wilson & Baddeley, 1989) for the first time 
with PD participants, in particular a sample of non-MCI PD participants many of whom were 
shown to be at risk for future progression, based on an initial “screening risk score” (Myall et 
al., 2015 AWCBR).  
1.3 Autobiographical Memory in Parkinson’s disease 
Autobiographical memory concerns both personal episodic memories and personal semantic 
memories, from an individual’s life. The personal episodic memories include specific details 
about experiences, events, people and times. Personal semantic memory includes more 
general factual information from these memories. The value of the AMI, designed by 
Kopelman, Wilson and Baddeley (1989) is that it is a standard instrument designed to assess 
‘personal episodic’ and ‘personal semantic’ memory separately in distinct and detailed 
sections. The AMI is broken up into two components, a personal semantic schedule and an 
autobiographical incident schedule with participants producing memories for each of these 
components from different periods of their life. This allows a comparison of recall of facts 
and incidents in a way that has not been possible in previous tests (Kopelman et al., 1989). 
Autobiographical memory is associated with both prefrontal cortex and medial 
temporal lobe function. Damage to the medial temporal lobe can impair ability to store new 
memories, and can cause loss of old memories (Squire, 1992). A correlational analysis of the 
amygdala, hippocampus and right inferior frontal gyrus found functional connectivity 
between these regions during episodic autobiographical memory retrieval but not semantic 
retrieval (Greenberg et al., 2005). These areas that show functional connectivity during 
autobiographical memory retrieval are often impaired in PD. This suggests that individuals 
with PD may have problems with autobiographical memory retrieval. 
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Only three studies have investigated autobiographical memory with PD groups (Table 
1). These studies focussed on public semantic and personal episodic memory (Sagar et al., 
1988), personal episodic and personal semantic memory (Smith, Souchay & Conway, 2010), 
and personal episodic memory only (Souchay & Smith, 2013). Each study found that PD 
participants experience some deficits in retrieving autobiographical memories (Table 1). 
However, these studies did used minimal cognitive testing to ascertain the cognitive status of 
their participants. The Mini-Mental Status Exam (MMSE) was the main cognitive measure 
for two of the aforementioned studies (Smith et al., 2010; Souchay and Smith, 2013), while 
the third used the Blessed Dementia Scale (BDS) (Sagar et al., 1988). One study added the 
Trail making and Stroop Tests (Souchay and Smith, 2013). A larger cognitive test battery 
would however be more accurate at determining the cognitive status of patients given their 
heterogeneous impairments (Hoops et al., 2009).  
An early form of autobiographical memory test, used by Sagar et al. (1988), showed 
that both PD and AD groups are more impaired at recalling content of personal remote events 
(personal events from a long time ago) than recent events. This test was called the Personal 
Remote Memory Test (modified from Crovitz and Schiffman 1974). Participants had to 
generate personal memories from any lifetime period in response to ten high frequency noun 
cues (for example, tree). Participants were given up to 4 minutes to recall autobiographical 
memories with as much detail as possible in response to each cue. If participants could not 
respond within the first two minutes, they were prompted with nonspecific cues (e.g. ‘tell me 
more’, can you think of one instance?’). The following day without warning, participants 
were given a second recall test for each word cue. If they failed to recall as much as they had 
recalled the day beforehand they were prompted after two minutes with key words from their 
memories (e.g. Onyx’). Healthy controls recalled full and detailed memories on day 1, with 
or without cues, and were able to fully reproduce these memories on day two. Participants 
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with AD were impaired at autobiographical recall on day 1, whether cued or un-cued, and 
were impaired further on their recall on day 2. AD participants with higher BDS scores 
performed worse.  PD participants were mildly impaired at recalling autobiographical 
memories on day 1, with or without cues, and showed a deficit at recalling these memories on 
day 2. Although when cued, the PD participants were able to recall as well as they had on day 
1. The high BDS score group of PD (4 participants, 3 of which had PDD) performed worse 
than the low BDS group (normal BDS score) on both days. Impaired performance was 
characterised by failure to recall time-specific events. Recall of public events (episodic and 
semantic), assessed by the Public Scenes test, also showed impairment in the PD and AD 
groups. Participants were shown photographs of famous scenes from the 1940’s to the 1980’s 
and had to indicate if they recognised them, and recall event, content, scenario and date 
information for each photo. PD and AD participants showed a gradient deficit, recent events 
were recalled more poorly than remote events. Again the high BDS PD group performed 
more poorly than the low BDS PD group. 
The other two studies used an autobiographical memory fluency task, where 
participants had 2 minutes to recall personal events (episodic) and 2 minutes to recall 
personal facts (semantic) in each of 5 lifetime periods, 0-18, 19-30, over 30 up until last 5 
years, the last 5 years, excluding the last 12 months, and the last 12 months (Souchay and 
Smith, 2013; Smith, Souchay & Conway, 2010).  In the first study, non-demented PD 
participants recalled fewer personal events (episodic and semantic) for recent time periods 
and had more difficulty recalling autobiographical events rather than autobiographical 
knowledge (Smith, Souchay & Conway, 2010). This difficulty was attributed to over-
generality, as PD patients could not recall specific memories. The second study analysed 
different PD participants and their recall of autobiographical memories with the same fluency 
task, but added a delayed recall phase (Souchay & Smith, 2013). There were three parts to the 
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delayed recall phase. First, free recall: participants were required to recall the personal events 
they had already given in exactly the same way. Second, cued-recall: participants were given 
the lifetime periods as general cues to retrieve events. Third, self-generated cues: participants 
were given a memory title they had previously assigned to each memory as individual 
memory cues. Compared to controls, PD participants were impaired at recalling memories in 
free recall and cued recall but performed comparable to controls in response to self-generated 
cues. This difference was attributed to retrieval process. Specific self-generated 
autobiographical memory cues may provide a direct route to memory retrieval while general 
cues may involve a search elaboration process, which is more cognitively demanding 
(Souchay & Smith, 2013). 
A potential limitation of the autobiographical memory fluency task is that the personal 
semantic knowledge section is limited. Participants were only required to recall names of 
people (excluding family or relatives) for each time period. The AMI, by contrast, provides 
an improved personal semantic memory measure as it takes into account not only names but 
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Autobiographical Memory Fluency Task - 
Participants recalled autobiographical 
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Trail making Task 
Stroop Task 
Autobiographical Memory Fluency Task + 
cues for AM retrieval 
 
three recall periods included free phase recall, 
general lifetime period cued-recall and recall 
cued by self-generated cues 
 
PD group impaired in 
free recall phase and to 
general lifetime period 
cues.  
 
PD group same as 
controls retrieving 
memories to self-
generated cues.  
Abbreviations: AD = Alzheimer’s disease; AM = Autobiographical memory; BDS = Blessed Dementia Scale; HC = Healthy control; MMSE = Mini-Mental Status Exam; 
NART = The National Adult Reading Test; PD = Parkinson’s disease; PDD = Parkinson’s disease with dementia; SD = Standard deviation 
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1.3.1 Autobiographical memory interview 
The AMI is a standard instrument designed to assess ‘personal episodic’ (autobiographical) 
and ‘personal semantic’ memory in distinct and detailed sections. The AMI addresses three 
broad time periods, childhood, early adult and recent life, each of which is further broken 
down into three more specific time periods. To assess autobiographical episodic memory, 
participants are required to recall specific memories from each of these 9 time periods. 
Detailed rather than general memories are encouraged, and prompts are used where the 
participants fail to recall on their own. To assess personal semantic memory participants are 
asked questions about their past that require knowledge of facts, such as dates of births and 
marriages, and names of friends. The broad range and specificity of the time periods covered 
in the AMI provides detailed information from the participants for both semantic and 
episodic memories. This test makes it possible to dissociate between semantic and episodic 
impairments and to compare performance across different time periods. 
Most AMI studies have examined Alzheimer’s disease patients. Autobiographical 
memory impairments are evident in the early stages of AD (Levy et al., 1998). In recall of 
autobiographical incidents, minimal and mild AD groups show a temporally graded loss, 
recalling fewer memories for recent time periods than remote time periods (Levy et al., 
1998). Amnestic MCI patients, who are at high risk for developing Alzheimer’s disease, also 
experience difficulty recollecting events from their entire lifespan, in particular, recently 
experienced events (Tramoni et al., 2012). Comparatively older adult controls show the 
opposite temporal gradient, as they can generally recall more autobiographical memories for 
recent time periods than earlier lifetime periods (Kopelman, 1989). This may reflect a general 




There is a similar impairment in recall of personal semantic memories and episodic memories 
in AD. Early stage AD patients also show a temporal gradient in semantic recall, recalling 
recent memories poorer than earlier memories (Levy et al., 1998).  Kopelman et al.(1989) 
found a similar pattern of results for the AMI with their cohort of AD participants, while their 
control participants performed in the reverse temporal gradient, recalling recent semantic 
memories better than childhood memories.  
A potential problem with using a recollection of personal events is checking accuracy. 
For example, confabulation is thought to occur in patients with both frontal lobe damage and 
memory deficits. Kopelman et al. (1989) assessed the accuracy of recall with Korsakoff’s and 
Alzheimer’s patients tested with the AMI by consulting their relatives. They found that the 
overall accuracy was high and that any inaccuracy and confabulation was minimal when 
compared to the magnitude of the deficit compared to controls.  By correlating the patients 
initial scores with the scores after consulting with relatives, they found a high correlation 
(0.88) indicating that detailed checking of responses is probably not necessary for most 
patients. 
The Autobiographical Interview (AI) of Levine is another measure of 
Autobiographical memory; however it is less sensitive to impairment than the AMI. The AI 
requires participants to recall a memory, and scores the semantic and episodic components 
from the same memory, compared to the distinctly separate sections in the AMI for each 
component. The AMI may sample fewer time periods (childhood, early adult life, and recent 
life) than the AI (early childhood, adolescence, early adulthood, middle age, and the previous 
year), but the AI requires fewer memories per time period.  In a recent study, individuals with 
dementia of the Alzheimer’s type (DAT) when tested with the AMI were again significantly 
impaired on both episodic and semantic memory with a significant temporal gradient sparing 
childhood memories (Barnabe, et al., 2012). By comparison DAT individuals tested with the 
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AI  in the same study only showed impairment on recall of episodic memories with a slight 
temporal gradient (Barnabe, et al., 2012).   
No studies have examined autobiographical memory in Parkinson’s disease using the 
AMI. Kopelman’s AMI is of value to PD research as it can be sensitive to temporal gradients 
in both episodic and semantic memory recall and separates these two components of lifetime 
memories. It appears that the current study is the first to use the AMI with PD patients.   
1.3.2 Theory of mind  
Theory of Mind (ToM) is the ability to understand and predict the behaviour of others. ToM 
is influenced by the integrity of the prefrontal cortex, which is often impaired in PD, so 
deficits in Theory of Mind tasks are anticipated. There is evidence to suggest that PD patients 
perform worse on ToM tasks than controls (Mengelberg and Siegert, 2003). However there is 
a large range of ToM tasks, not all of which show deficits with PD patients (Poletti et al., 
2011).  Table 2 shows the range of affective theory of mind tasks used in PD and Table 3 
shows the range of cognitive theory of mind tasks used in PD. The tables are ordered by ToM 
‘tasks used’ to group together the main findings for each task, so there is some repetition of 





Affective Theory of Mind tasks used in PD studies. Tasks are listed in alphabetical order. 
Tasks  Researchers Test Details Participants Hoen and 
Yahr Stage 






















Participants read a story that 
may contain a social faux pas. 
The affective component of the 
test is recognizing that the 
person committing the faux pas 
was unaware of saying 
something inappropriate, and 
recognizing that the person 
hearing the faux pas might have 
felt hurt or insulted. 
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Complex Rey figure and 
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Wisconsin Card Sorting Test. 
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following for the advanced PD 
patients:  MCST, TMT, 
categorical and literal fluency 
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German intelligence test battery 
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Rey auditory verbal learning 
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2-3 MMSE, WCST, maze-tracing 
subtest of WISC-R, The Stroop 
Color Word naming Test, 
Verbal fluency with Japanese 









Yoni task  Bodden et 
al., 2010 
60 items presented on a  
computer screen, a face named 
Yoni in the middle with 4 
coloured pictures of faces or 
objects in the corners 
affective first order = Yoni’s 
mental state inferred (‘Yoni 
likes…’) 
Affective second order = Yoni’s 
ToM process inferred (‘Yoni 
likes the fruit that…likes’) 
21 PD nondemented 
(20 medicated), 21 HC 
2.5 (Range 
1.0-3.0) 
MMSE (cut-off: >26), PANDA, 
memo test (immediate and 
delayed recall) digit span 
forward and backward from 
WMS-R, verbal and semantic 
fluency tasks (FAS and 
animals), TMT, subtest 4 of the 










Abbreviations: DBS = Deep Brain Stimulation; F, A, S = letters tested ; FPR = Faux Pas Recognition; HC = Healthy Controls; LPS = Leistungsprufsystem; MCST = 
Modified Wisconsin Card Sorting Test; MDRS = Mattis Dementia Rating Scale; MMSE = Mini-Mental Status Exam; PANDA = Parkinson Neuropsychometric Dementia 
Assessment; PD = Parkinson’s Disease; RME = Reading the Mind in the Eyes; TMT = Trail Making Test; WISC-R = Wechsler Intelligence Scale for Children; WMS-R = 
Wechsler memory Scale-Revised 




Table 3  
Cognitive Theory of Mind tasks used in PD studies. Tasks are listed in alphabetical order. 
Tasks  Researchers Test Details Participants Hoen and 
Yahr Stage 







A clip was hidden under 4 egg cups, the 
‘examiner’ and another person pointed to where 
they thought the clip was (examiner always 
correct). The participant had to indicate where 
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Vocab subtest of WAIS-
R, CCST, verbal fluency 
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provided with a written copy. The first order 
false belief question required participants to 
describe a person’s belief about the world. The 
second order false belief question required the 
participant to indicate what the protagonist 
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Recognition Memory 
test for faces and words, 
Benton phoneme 
discrimination and face 
recognition subtests, 
verbal fluency test. 



































Visual false belief task: the card sequencing 
task: 18 story sequences presented on 4 cards 
using cartoon drawings, a false belief category 
involving a character acting on a false belief 
because he/she is unaware of a prior event + 
control conditions. 
 
Participants read a story about two characters 
involved in a routine activity, the first order 
false belief question tested the ability to make an 
inference about another person’s mental state. A 
second story was read and participants had to 
answer a second order false belief story that 
required the understanding of “One character 
thinks that another character thinks…’ 
 
False belief stories: participants were read a 
story and also provided with a written copy. 
Participants were asked to make a prediction 
regarding the behaviour of one of the characters 
in the story based on the information available. 
The answer required inferences based on mental 



















































MMSE (cut-off: >26), 
Vocab subtest of WAIS-
R, CCST, verbal fluency 















































Participants read a story that may or may not 
contain a social faux pas. 10 stories contain a 
faux pas and 10 do not. After reading each story 
the participant is asked if the character 
committing the faux pas was aware that 
something inappropriate had been said, and if 







A shortened version of the faux pas test, using 5 
stories with faux pas and 5 stories without.  
36 PD (16 
medicated 20 











17 early PD 
nondemented on 
and off meds 
(abstain from 
meds night before 
assessment, 26 
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MMSE (score: >24), 
categorical/phonologic 
verbal fluency, short 
version Boston Naming, 
short version Token test, 
Rey auditory verbal 
learning test, delayed 
recall of the Complex 
Rey figure and attention, 
TMT A and B, digit 
forwards and backwards 
span, WCST. 
 
MDRS (score >130), 
plus the following for 
the advanced PD 
patients:  MCST, TMT, 
categorical and literal 










































Participants were shown a full picture and then 
half of it was hidden. They were then asked 







2.5 MMSE (cut-off: >26), 
Vocab subtest of WAIS-
R, CCST, verbal fluency 










Participants were required to read a story and 
answer questions about the text. The theory of 
mind questions required the participant to make 
inferences about the characters feelings, 










MMSE, NART Impaired 
Spy task Saltzman et 
al., 2000 
Participants were the spy on a game board and 
had to retrieve a document without getting 
caught. Participants were told they were 
dripping wet and had to demonstrate or explain a 
solution to this puzzle, (e.g wiping up wet tracks 
as they went). A correct solution demonstrated 
the understanding that they had to hide their 





2.5 MMSE (cut-off: >26), 
Vocab subtest of WAIS-
R, CCST, verbal fluency 





Yoni task Bodden et 
al., 2010 
 
60 items presented on a  computer screen, a face 
named Yoni in the middle with 4 coloured 
pictures of faces or objects in the corners 
Cognitive first order = Yoni’s mental state 
inferred (Yoni likes the fruit that … likes’) 
Second order = Yoni’s ToM process inferred 








MMSE (cut-off: >26), 
PANDA, memo test 
(immediate and delayed 
recall) digit span 
forward and backward 
from WMS-R, verbal 
and semantic fluency 
tasks (FAS and 
animals), TMT, subtest 
4 of the German 









Abbreviations: CCST = California Card Sorting Task; DBS = Deep Brain Stimulation; F, A, S = letters tested; FPR = Faux Pas Recognition; HC = Healthy Controls; LPS = 
Leistungsprufsystem; MDRS = Mattis Dementia Rating Scale; MMSE = Mini-Mental Status Exam; NART = National Adult Reading Test; PANDA = Parkinson 
Neuropsychometric Dementia Assessment; PD = Parkinson’s Disease; RME = Reading the Mind in the Eyes; TMT = Trail Making Test; WAIS-R = Wechsler Adult 
Intelligence Scale-Revised; WCST = Wisconsin Card Sorting Test; WMS-R = Wechsler memory Scale-Revised 
Table adapted from Poletti, Enrici, Bonuccelli & Adenzato, 2011. 
22 
 
It is proposed that there are two separate 
systems involved in ToM tasks (Poletti, Enrici, 
Adenzato, 2012). Cognitive ToM tasks involve 
processing inferences about others beliefs and 
intentions and inferring their mental states, 
whereas the affective tasks involve processing 
inferences about other people’s emotions and 
feelings. Each of these ToM categories may have 
different underlying neural correlates: the 
dorsolateral PFC influences cognitive ToM 
performance, whereas the ventromedial PFC 
influences affective ToM (Figure 2). Across studies, PD patients have greater difficulty 
performing in cognitive theory of mind tasks than affective theory mind tasks (Tables 2 & 3). 
That is, most of the affective ToM tasks shown in Table 2 are preserved, whereas most of the 
cognitive tasks in Table 3 show impairments.   
Of the affective theory of mind tasks outlined in Table 2, one study reported 
impairments. Another study showed impairments in the PD group after DBS but not 
beforehand; the dysfunction may be due to STN micro lesions or stimulation (Peron et al., 
2010). The two impairments in affective ToM were found in one study using the Yoni test 
and Reading the Mind in the Eyes test (Bodden et al., 2010). The fact that these tasks show 
impairment in this PD group but previous research has shown a lack of impairment may be 
due to the patient group being in a more progressed stage of the disease. The average Hoen 
and Yahr stage of the PD participants who showed impairment is 2.5 (Bodden et al., 2010), 
this is the highest of all the studies in Table 2.  One theory proposes that affective ToM may 
not be influenced until later stages of the disease because of the spatio-temporal depletion of 
Figure 2. A model describing the relationship 
between the two neural systems for 
cognitive and affective ToM processing 




dopamine (Poletti et al., 2011).  In the later stages of PD, the frontostriatal circuits that 
connect the basal ganglia with medial regions of the prefrontal cortex are affected by 
dopamine depletion and these areas are thought to be important in affective ToM 
performance. However the one study in Table 2 that did assess performance of early and late 
stage PD and affective ToM found no significant differences between patients at either stages 
of the disease (Peron et al., 2009).  
Of the cognitive ToM tests (Table 3), most showed impairments in PD groups, but 
some tasks did not show impairments in PD groups compared to controls. Two tasks that 
showed preserved ToM were the deception task and the perspective taking task from 
Saltzman et al. (2000). These tasks had variable performance levels by PD participants even 
though the task is usually completed by very young children. Peron et al., (2009) found that 
performance on the faux pas recognition test was unimpaired in early PD but impaired in 
advanced stage PD. They suggest that a deficit may not be evident until a degenerative 
process has spread beyond the dopaminergic pathways. But these results contradict two other 
studies that did find impairment in early PD with this task (Roca et al., 2010; Kawamura & 
Koyama, 2007). The results of Peron et al. (2009) may not be comparable to the results of 
Roca et al. (2010) and Kawamura and Koyama (2007) as they used a shortened version of the 
faux pas recognition task and had a much smaller sample size. PD participants were 
unimpaired on the first order component of the Yoni test but were impaired on the second 
order component (Bodden et al., 2010). First order tasks are easier than second order tasks; 
however, Mengelberg and Siegert (2003) showed the opposite effect. In the first order false 
belief stories, participants had impaired functioning compared to controls but there was no 
significant difference between PD and controls on the second order task. The equal 
performance of PD and controls could be due to a high working memory load, as both PD 
and controls performed poorly. This shows that some cognitive ToM tasks may instead 
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reflect executive functioning deficits and thus provide ambiguous measures of cognitive 
ToM.  
One study suggested there may be a relationship between measures of cognitive ToM 
and executive functioning, but did not assess comprehension or reasoning ability in order to 
control for deficits in these areas (Saltzman et al., 2000). By contrast, Mengelberg and Siegert 
(2003) replicated the study of Saltzman et al. (2000) and added control questions along with 
different measures of ToM (visual and text based) (Table 2). PD participants scored 
significantly lower on three out of four ToM tasks (card sequencing task, short passages, and 
first order false belief story), but were not impaired on any of the non-ToM components 
which included inference, understanding and memory questions (Mengelberg & Siegert, 
2003). Hence impairments in executive functioning may not be necessary for the PD 
participants to show poor ToM performance.  
The card sequencing task designed by Langdon et al., (1997) is a useful ToM task as 
it dissociates between theory of mind impairment and executive functioning deficits. This 
task will be used to examine whether performance on Theory of Mind tasks differs between 
at-risk non-MCI PD patients and healthy controls. This card sequencing task is a good 
measure of theory of mind as it enables control conditions to address non theory of mind 
issues like poor sequencing, social understanding and complex reasoning. There are four card 
categories: false belief, social situations, mechanical and capture. Highly functioning autistic 
children and Schizophrenic adults can have selective difficulty sequencing false belief stories 
but can perform equally or better on social script and mechanical conditions (Langdon & 
Coltheart, 1999). The card sequencing task is also a useful measure as it is a visual task and 




1.4 A Link between Theory of Mind and Autobiographical Memory: 
Default Mode Network 
Research has consistently identified a distributed group of brain regions that form the DMN. 
These are the medial posterior cortex (particularly the posterior cingulate cortex and the 
precuneus), the medial frontal cortex, and the bilateral inferior parietal and posterior temporal 
areas around the temporoparietal junction (Mars et al., 2012). Figure 3 shows the default 
mode network (DMN) hubs, plus the two key subsystems and each component’s 
hypothesised function (Andrews-Hanna, 2012). The DMN is a distribution of separate brain 
regions that show functional connectivity and high basal activity when an individual is at rest 
Figure 3. Major default mode network components. The arrows represent approximate strength 
of connectivity between components. The DMN hubs are yellow (PCC , aMPFC), the 
dMPFC subsystem is blue and the MTL subsystem is green. (Andrews-Hanna, 2012).  
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and not engaged in an externally demanding task. The DMN appears to be active during 
external-stimulus independent thought. By contrast, there is generally decreased activity in 
the default mode network during externally directed task-related activity.  
Relevant to the current study, the DMN has been shown to be activated by both 
autobiographical memory tasks and theory of mind tasks (Andrews-Hanna, 2012). The fact 
that the same network underlies functioning on both of these tasks suggests that performance 
on these tasks may be correlated. While autobiographical memory and theory of mind have 
traditionally been studied separately, recent fMRI studies have revealed extensive functional 
overlap in the core brain networks that underlie these processes (Spreng et al., 2008). That is, 
the default mode network increases in activity during both autobiographical memory and 
theory of mind tasks. This overlap is exhibited most reliably in the medial prefrontal, medial-
temporal and medial lateral parietal cortices, that is, key regions of the DMN. Specifically, 
the hubs highlighted in Figure 3, namely the posterior cingulate cortex and the anterior 
medial PFC, underlie the functioning of both autobiographical memory and ToM (Andrews-
Hanna, 2012). However, relative differences between the two phenomena are found in that 
autobiographical memory tasks predominantly engage the MTL subsystem and theory of 
mind tasks predominantly engage the dMPFC subsystem (Andrews-Hanna, 2012).  The 
theory of mind tasks that were used to evaluate the dMPFC, involved inferring other people’s 
mental states, although these were mainly affective ToM tasks. Research also suggests that 
midline regions like the medial prefrontal cortex help with coding emotions in mental state 
attribution (affective ToM) and that the lateral prefrontal cortex supports externally generated 
representations and might code cognitive aspects of mental state attribution (cognitive ToM) 
(Olsson & Ochsner, 2007). Nonetheless, the overlap at the level of the key hubs, suggest 
overlap in terms of memory-based construction (autobiographical episodic retrieval) and 
cognitive theory of mind tasks (mentalizing the state of others and social reasoning). 
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Individuals with PD may have reduced functional integrity of the DMN, which may 
contribute to the development of cognitive decline. Cognitively unimpaired PD patients 
(defined by cognitive domain z scores that are not below the population mean in any of 3 
domains) and who show no significant structural differences compared to controls, 
nonetheless show functional disruption of the DMN (Tessitore et al., 2012). These patients 
were at stages 1 and 2 of the Hoehn and Yahr scale, which represent mild disease stage. PD 
patients, showed decreased functional connectivity in the right medial temporal lobe and 
bilateral inferior parietal cortex in the DMN. Given that the DMN shows early functional 
disruption, detecting cognitive changes in tasks related to DMN functioning could be a good 
predictive measure of future decline. That is, it is of value to identify functional 
neuropsychological tests that can identify cognitive change in early PD prior to significant 
changes to patient’s cognitive status, such as PD non-MCI to PD-MCI. Autobiographical 
memory and theory of mind tests may be suitable to detect these early cognitive changes as 
performance on these tasks may be dependent on the functioning of the DMN.   
1.5 The current study 
The current study examined both autobiographical memory and theory of mind in individuals 
who are in early stages of PD but do not have MCI. Performance on these tasks was 
compared to that shown by age, education and sex matched healthy controls (HC). The AMI 
was used as a standard instrument to assess both autobiographical and personal semantic 
memory explicitly. The card sequencing task mentioned above was used to assess cognitive 
theory of mind. It was expected PD participants would show deficits in both autobiographical 
memory and theory of mind compared to the HC group, and that there would be an 
association between the two measures that may be related to overlapping changes to the 
default mode network. In addition, these measures were assessed in terms of their potential as 
early markers of future cognitive decline. For this latter aim, the association between the AMI 
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and ToM measures was assessed with an independent risk score derived from a short screen 
developed at the NZBRI (Myall et al., 2015 AWCBR). This risk score takes into account the 
scores of the MoCA, the Stroop-inference, Trails B, the Test of Everyday Attention (TEA) 
Map Search, as well as age of an individual, to discriminate between converters to PD-MCI 

















Patient volunteer participants were sought from current Christchurch Neurology and 
Movement disorders clinics. Of 238 participants contacted, 195 completed initial cognitive 
screening that lead to 20 participants eligible to participate in cognitive testing for the current 
study (see Figure 3). This group included 2 participants below 29% risk of conversion to 
dementia within 4 years and 19 participants above 29% risk of conversion to dementia within 
4 years. This percentage risk of conversion was determined with an algorithm designed by 
Daniel Myall based on the scores of the initial screening assessment in an earlier cohort and 
based on an analysis of progression over 4 years of PD normal (PD-N) patients to either PD-
MCI/PDD. The 29% was determined to be the optimal ROC cut-off (Youden Index) for 
progression to PD-MCI/PDD that gives the optimal sensitivity and specificity, to discriminate 
PD patients who do/do not show cognitive decline to PD-MCI /PDD across the next four 
years after screening. So the over 29% risk score group can be considered ‘pre-MCI’. The 
patients eligible for the study as determined by the screening test, undertook two sessions of 
detailed neuropsychological cognitive status testing (covered by a HRC project) to establish 
PD-MCI or non-MCI status. Inclusion criteria were a diagnosis of PD without confounding 
atypical movement disorders.  Exclusion criteria were involvement with studies that include 
pharmacological intervention, history of major medical or psychiatric illness in the past 12 
months, current or history of other neurological or psychiatric conditions, medications 
impacting cognition, history of alcohol or substance abuse, history of learning disability, poor 
comprehension of the English language, patients under the age of 60 and over the age of 85, 
and patients with PD who meet criteria for PD with mild cognitive impairment (PD-MCI) or 




Clinical and Demographics of Participants (mean (SD)) 
 PD (n = 20) Healthy Controls (n = 15) p 
Sex, M:F 13:7 9:6  
Age 73.25 (6.53) 74.27 (6.23) 0.65 
Education (y) 13.05 (2.21) 14.53 (2.31) 0.08 
HADS Anxiety 4.55 (3.07) 3.07 (3.31) 0.18 
HADS Depression 3.45 (2.31) 2.27 (2.15) 0.13 
GDS 0.15 (0.67) 0.13 (0.52) 0.94 
Symptom duration (y) 8.55 (5.24) -  
Risk score 51.67 (0.22) -  
Hoehn and Yahr stage 2.55 (0.58) -  
UPDRS (motor) 34.75 (14.38) -  
DRS-2 (AESS) 11.55 (3.15) -  
ADAS-Cog 6.54 (2.07) -  
Abbreviations: ADAS-Cog = Alzheimer’s Dementia Assessment Scale-Cognitive; DRS-2 (AESS) =  
Dementia Rating Scale (age and education scales score); GDS = Geriatric Depression Scale; HADS =  
Hospital Anxiety and Depression Scale; UPDRS = Unified Parkinson’s Disease Rating Scale 
 
Fifteen healthy controls identified from the NZBRI database were contacted and 
matched to fifteen of the PD participants based on age, education (see table 4 for a summary 





















Potential PD participants contacted 




Excluded (n = 43): 
Declined - N=32 
Couldn’t complete screening test =4 
Hx of Psych Illness =1 
Already in another study =1 
Not PD =1 
Screened for clinical reasons only =1 







NP cognitive status testing  
x2 sessions (to confirm non-MCI) 
n = 126 
Non-MCI PD Participants 
recruited 
n = 20 
 
Excluded (n = 69): 
Declined = 13 
Unwell = 12 
PD-MCI = 8 (based on screening) 
Deceased = 2 
Distance = 14 
Too Young = 18 
DBS = 1 
Major depression =1 
 
Excluded (106): 
Testing incomplete in time = 49 
PD-MCI = 52 
PDD = 3 
Declined = 1 




2.2 Initial Cognitive Screening Tests 
Parkinson’s patients underwent an initial screening assessment to determine their cognitive 
status as part of a larger HRC study on PD-MCI at the NZBRI. The screening assessment 
took approximately 20-30 minutes and consists of the MoCA, the Stroop test, the Trails test 
version A and B, and the Test of Everyday Attention Map Search. The NZBRI has shown 
that these screening tests, when adjusted for age, provide a sensitive composite measure of 
probability of future progression to PDD (Myall et al., 2015 AWCBR). Healthy controls also 
completed this short screening test. 
2.3 Neuropsychological Assessment to establish non-MCI status 
Testing was completed across two sessions that took 2 to 3 hours each using procedures 
prescribed in the appropriate manuals. The tests used covered the five cognitive domains 
required by the Movement Disorders task force Level II criteria (Litvan et al., 2011). 
Attention, working memory and processing speed was assessed using the Digits Forwards 
and backwards Test, Digit Ordering (Wechsler, 2008), TEA (MAP Search) (Robertson, 
Ward, Ridgeway, & Nimmo-Smith, 1994), Trails A, and DKEFS Stroop colour and Stroop 
word (Delis, Kaplan & Kramer, 2001). Executive function was assessed by Trails B, D-KEFS 
letter fluency, category fluency, category switching and the colour word inference test 
(Stroop) (Delis, Kaplan & Kramer, 2001) and action fluency (Piatt, Fields, Paolo, & Troster, 
2004). Visuospatial functioning was tested with the judgement of line orientation (JLO) 
(Benton, Hasher, Varney & Spreen, 1983), the fragmented letters subtest of the visual object 
and space perception (VOSP) (Warrington & James, 1991), the Rey-Osterrieth Complex 
Figure Copy (Meyers & Meyers, 1995), pentagons and the Wechsler Adult Intelligence Scale 
IV picture completion task (Wechsler, 2008). Learning and memory was assessed learning 
with the short from California Verbal Learning Test II (Delis, Kramer, Kaplan & Ober, 2000) 
and immediate and delayed recall of the Rey-Osterrieth Complex Figure (Meyers & Meyers, 
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1995). Language was assessed with the Boston naming test (Kaplan, Goodglass, & 
Weintraub, 1983), the similarities component in the Dementia Rating Scale-2 (Jurica, Leitten 
& Mattis, 2001), and the language component of the ADAS-Cog (Mohs et al., 1997). 
2.4 Cognitive Testing session for the current study 
2.4.1 The Autobiographical Memory Interview (AMI) 
Using the AMI (Kopelman et al., 1989), participants were required to recall personal 
semantic details and autobiographical episodic incidents by answering questions from three 
lifetime periods: childhood, early adult life and recent life.  Within each lifetime period there 
were three sections that focused on key events specific to that time period. Within the 
‘childhood’ period, the subsections focused on: period before school, first school, secondary 
school. Within the ‘early adult life’ period, the subsections focused on: career, wedding and 
children. Within the ‘recent life’ period, the subsections focus on: present hospitalisation, 
previous hospitalisation, last Christmas, and a holiday.  
Each subsection of the AMI contains personal semantic questions and an 
autobiographical incident (episodic) question. The personal semantic questions require 
participants to recall facts such as names of teachers or friends, date and place of wedding 
and the time and location of holidays. When the participant was unable to answer, prompts 
were provided to stimulate a response, for example if a participant is struggling to recall 
teachers or friends names they were asked, ‘can you name your form teacher? A friend?’ The 
autobiographical questions required the participants to provide specific and detailed 
memories for each subsection, each specific to a different time frame. Prompts were provided 
to stimulate a response when the participant could not think of an incident. For example, for 
an incident at college they were asked, ‘can you think of an incident from your first day at 
college, or an incident with a friend?’  Participant responses were recorded as accurately as 
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possible and verbal responses recorded on a Zoom H4N recorder, with their permission, to 
improve accuracy. AMI testing took 30 to 50 minutes on average.  
2.4.2 Theory of Mind Task - card-sequencing task (Langdon et al., 1999)  
This task used short story sequences presented on cards depicting black and white cartoon-
like drawings. Each story had 4 cards (21cm x 15cm). The cards for any given story were 
presented face down in a line in front of the participant. The participant was asked to turn the 
cards over of any given story and rearrange the cards in the correct sequential order. There 
were two practice sequences (mechanical) followed by 4 stories of 4 cards in each for each of 
four conditions: (a) False belief: a character acts on a false belief because they are unaware of 
an event that occurred prior; (b) A social script: character(s) involved in a daily activity; (c) 
Mechanical: Objects interacting; (d) Capture: depicting routine activities but a misleading cue 
makes the sequence more complex. The last three conditions were used to control for 
sequencing errors caused by factors other than false belief ToM deficits. These control 
conditions tested participant’s ability to reason logically (social script), to infer causal 
relations (mechanical), and to disengage from a cognitively salient misleading cue (capture). 
The semi-random order of the cards for any given story was determined by coloured dots on 
the back (orange, blue, yellow, green) so that the cards were presented to each participant in 
the same random order. The order that the stories and order of the conditions were presented 
in was also semi-random. Appendix A shows the scoring sheet which also shows the order 
the cards are presented in. 
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2.4.3 Other Cognitive Tests 
2.4.3.1 The Brief Visuospatial Memory Test-Revised (BVMT) (Benedict, 
1997) 
Participants were presented with 6 figures (objects) on a single page in the recall stimulus 
booklet to study for 10 seconds and then asked to recall each figure by drawing them in the 
response form as they appeared and in their correct location on the page. This procedure was 
repeated for a total of 3 learning trials. After a delay of 25 mins of verbal tasks, a delayed 
recall trial was administered.  Participants were given points for drawing the correct object 
shape, and for drawing it in the correct location, there was a maximum of 12 points for each 
trial. A recognition trial was administered immediately after the delayed recall trial. 
Participants were shown the 12 figures one at a time and had to indicate if they had or had not 
previously seen the figures on the display (6 figures were from the display and 6 figures were 
new). 
2.4.3.2 The Symbol Digit Modalities Test (SDMT) (Smith, 1982) 
Participants were administered the written response format of the SDMT. Participants were 
required to use a coded key to match 9 abstract symbols paired with numerical digits. 
Participants were given 10 practice items and corrected immediately if they made any errors. 
Participants were then required to match as many symbols to the correct numbers within 90 
seconds.  
2.4.3.3 The Sydney Language Battery (SYDBAT) (Savage et al., 2013) 
Participants completed the four subtests of the SYDBAT: naming, repetition, word 
comprehension and semantic associations, there were 30 items in each subtest. For the 
naming task, participants were required to provide the name of an item shown in a colour 
photograph, presented one at a time for a total of 30 items. Mispronunciations of words due 
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to phonemic, phonological, or semantic substitutions were considered errors. For the 
repetition task, participants were required to listen and repeat each of 30 words after the 
tester. For the word comprehension task, participants were required to select a picture shown 
on screen that best matched the word spoken by the tester (30 word were used). The correct 
picture had to be selected out of one target item and six foils, which were semantically close 
to the target or visually similar. The semantic association task required participants to select 
one picture from a set of four options that was most closely associated with the target picture 
(30 pictures were used). The four options were semantically related to each other but only 
one was closely related to the target. Administration of all four subtests took approximately 
20 minutes.  
2.4.4 Psychiatric Tests 
All participants were given the Hospital Anxiety and Depression Scale (HADS) (Zigmond & 
Snaith, 1983) and the 15 item brief version of the Geriatric Depression Scale (GDS) 
(Yesavage et al., 1983). 
2.5 Procedure 
This study was approved by the Northern B Health and Disability Ethics Committee of New 
Zealand. Informed consent was given by all participants prior to the initial screening session. 
Participants completed the screening session in quiet test rooms at the NZBRI or at the 
Movement Disorders clinic in Christchurch. Participants were then invited to take part in the 
neuropsychological assessment (2 sessions) at the NZBRI to establish their PD-N or PD-MCI 
status. Based on this full neuropsychological assessment, participants who were eligible were 
invited to take part in the testing for the current study. For the current study, participants 
received the SDMT, the Autobiographical Memory Interview, the card sequencing task, the 
BVMT, and the SYDBAT. All tests were given in that order during one session which took 1 
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to 1.5 hours, except for the SYDBAT which was given to the PD participants as part of 
another session a few days later (this session was part of a larger study using the same 
participant group). The testing for the current study took place within 7 months of the full 
neuropsychological assessment. Matched healthy control participants completed the last list 
of neuropsychological tests listed above along with the initial screening tests (they did not 
complete the two sessions for the main neuropsychological assessment).  
2.6 Statistical Analyses 
Group comparisons using independent t-tests assessed the majority of measures, with non-
parametric equivalents (Mann-Whitney) when appropriate. Between-within ANOVA was 
used when repeated measures were examined in the AMI and the BVMT. Additional factors 
were added as covariates in a series of ANCOVAs. The association between two scores were 











3.1 Initial Cognitive Screening 
Table 5 summarises the performance of the PD and HC participants in the screening tests and 
the specific cognitive tests included in the current study. Scores were age and education 
adjusted where possible using normative data supplied by manuals. In the case of the SDMT, 
normative data was taken from a study using a sample of 14,456 Australian participants 
(Kiely, Butterworth, Watson & Wooden, 2014). Normative data for the SYDBAT was taken 
from the average performance of the control group provided by Savage et al. (2013). Of the 
screening measures, the MoCA, Stroop-inference, and TEA Map Search showed large mean 
differences between the PD and HC groups, (see effect sizes (ES), Table 5). A similar large 
effect of impaired performance in the PD group was found for SDMT, but the BVMT total 
and delayed recall showed even larger impairments in the PD group. No impairment was 
found in the PD group for any of the four language measures. Appendix B shows the results 
of the more general cognitive status testing for the PD participants. As a group, Appendix B 
shows that the PD participants performed above average when compared to normative data 
on most tests (Digits Forward and backward, Stroop word and inference, Trails A and B, 
Letter fluency, Category fluency, VOSP, Picture Completion, CVLT free recall, short delay 
recall and long delay recall, Rey Immediate, Rey delay, and the Language ADAS-cog). Some 
tests do suggest a mild impairment in the PD group (digit ordering, TEA Map Search, Action 
Fluency and the Rey Copy). However, no individual PD participant was impaired (more than 
1.5SD below the mean) at more than one test across different domains. Results of this more 
general neuropsychological testing show that none of the participants met PD-MCI criteria.  
Appendix C shows the scores of the two under 29% risk score participants for the screening 
tests and other key measures. The two under 29% risk score participants scored equal to or 
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higher than the average HC on the MoCA, and higher than HC on all other screening 
measures except the TEA Map Search.  
Table 5 
Means (SD) and effect sizes of the screening test and other cognitive measures. 
 PD mean (SD) 
(n = 20) 
HC mean (SD) 
(n=15) 
Effect size (d) 
(95% CI) 
Screening Tests    










0.48 (-0.2 to 1.2) 
0.48 (-0.2 to 1.2) 
0.85* (0.2 to 1.5) 
Trails A (z-score) 





0.61* (-0.1 to 1.3) 
0.12* (-0.6 to 0.8) 
TEA Map Search** (z-score) -0.82 (0.62) 2.69 (5.52) 0.97* (0.3 to 1.7) 
Other Cognitive Measures    
Visual Memory (z-scores) 
BVMT – Total Recall 








1.71* (1.0 to 2.4) 
1.49* (0.8 to 2.2) 
Attention/Recognition 









1.08* (0.4 to 1.8) 
Language (raw scores) 



















0.10 (-0.6 to 0.8) 
0.00 
-0.56 (-1.3 to 0.1) 
-0.40 (-0.3 to 1.1) 
Note: * p<.05 
** = tasks used in the model for the PD-MCI/PDD risk score  
BVMT Total recall is the sum of recall from Trial 1, 2 and 3. 
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3.2 The Brief Visuospatial Memory Test-Revised (BVMT) 
Figure 4 shows the mean scores for learning trials 1 to 3 and the delayed recall trial. There 
was a significant main effect of group, HC correctly recalled more figures than PD over trials 
1, 2 and 3 (F(1,33) = 24.17, p < 0.001). This main effect remained when controlling for age, 
sex and education (F(3,28) = 7.03, p < 0.002) and anxiety and depression (F(3,29) = 7.42, p < 
0.001). Both PD and HC groups correctly recalled a greater number of figures in their correct 
locations as the learning trials increased (F(2,66) = 148.74, p <0.001). The improvement in 
recall was greater between trial 1 to 2 (F(2,32) = 12.00, p <0.001), than between trial 2 to 3 
for both groups (F(2,32) = 10.64, p < 0.001). However, there was no group by trial 
interaction (F(2,66) = 1.14, p = 0.33). Recall at trial 3 and at delayed recall 25 minutes later 
was similar, with no significant difference in scores between these two recall periods (F(1,33) 
= 3.10, p = 0.09), but the HC group again recalled significantly more than the PD group at 






























































Trial 1 Trial 2 Trial 3 Delayed Recall
HC
PD
Figure 5 shows the distribution of individualised raw scores across trials for both groups, 
showing a broad range of scores in the PD group across all trials. Trial 3 had the most 
variation in raw scores between PD participants (SD = 2.45), whereas for HC participants, 
trial 3 had the smallest range of raw scores out of the different recall periods (SD = 1.40). 
When the analysis of scores for trials 1 to 3 were re-run without the 2 under 29% risk of 
conversion participants, there was still a main effect of group (F(3,29) = 7.44, p <0.001. The 
two under 29% risk score participants scored 3 and 3 for trial 1, 8 and 6 for trial 2 and 10 and 
10 for trial 3. These scores can be seen in Figure 5. These scores were on or above average 
compared to the mean of PD participant scores. The trial 3 recall scores of the two under 29% 
risk score participants were 10 and 10 and the delayed recall scores were 10 and 9, so there 
Figure 5. Distribution of individual raw scores across BVMT trials for both groups. Horizontal lines represent 
means; vertical lines = SEM. 
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was no difference between the overall recall of the PD group at these two recall periods when 
these were removed. The significant difference between PD and HC at delayed recall 
remained (t(31) = 4.35, p< 0.001). These delayed recall scores were 0.9 and 0.5 standard 
deviations above the mean.  
Table 6 shows the mean recognition scores for both PD and HC groups. Recognition 
hits show the correct identification of figures already displayed during the BVMT recall trials 
(max 6), false alarms show the incorrect recognition of figures that were not displayed in the 
recall trials (max 6) and the recognition discrimination index reflects the ability to 
discriminate previously presented target stimuli from non-target stimuli, this is the best 
measure of recognition memory. As shown in Table 6, there is no difference between PD and 
HC groups on any recognition measure (Mann-Whitney U pairwise comparison p >0.2) 
Table 6 





 PD (n = 20) HC (n = 15) 
Recognition Hits 6 (4-6) 6 (4-6) 
Recognition False Alarms 0 (0-2) 0 (0) 
Recognition Discrimination Index 6 (3-6) 6 (4-6) 



















3.3 The Symbol Digit Modalities Test 
Figure 6 shows the age and education weighted z scores of both PD and HC. PD participants 
scored significantly lower on the SDMT than the HC group (t(33) = 3.16, p<.01). There was 
greater variation in the z scores of the PD group; however, the majority of PD participants are 
performing below average (13 out of 20 PD, as opposed to 7 out of 15 HC). When the 
analysis of scores for the SDMT were re-run without the 2 under 29% risk of conversion 
participants, there was still a significant difference between PD and HC performance (t(31) = 
3.85, p <0.001). The two under 29% risk score participants achieved high z scores of 1.32 








Figure 7. Distribution of scores on the four subtests of the SDMT for Parkinson’s disease and healthy control participants. The 
horizontal lines show the means for each subtest from the control sample from Savage et al. (2013). 
3.4 The Sydney Language Battery (SYDBAT) 
Figure 7 shows the distribution of scores for PD and HC for each subtest of the SYDBAT. 
There were no significant differences between PD and HC on any of the four subtests (Mann-
Whitney U, p > 0.50). Every participant from both the PD and HC group scored a perfect 
score (30) for the repetition subtest. Participants from both groups scored highly for the other 
subtests of naming, word comprehension and semantic association (means (SD) and effect 
sizes are shown in Table 5). The horizontal lines represent the mean of a sample of healthy 
controls from Savage et al. (2013). Both HC and PD groups perform slightly lower than the 
normative mean control group for the naming subtest but similar to that control group on the 
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3.5 Theory of Mind (ToM) and sequencing tasks 
Figure 8 shows the raw scores for PD and HC across the 4 card sequencing tasks. Only the 
false belief task (ToM condition) showed a difference between the two groups, with poorer 
accuracy in the PD group (t(33) = 2.55, p = 0.02; Newman-Keuls p=0.01; ES = 0.87 (0.2 to 
1.6)). This difference between groups remained when controlling for age, sex and education 
(F(1,30) = 4.48, p < 0.05) and when controlling for anxiety and depression (F(1,31) = 7.31, p 
< 0.02). No group differences were evident for any of the other 3 card sequencing tasks (t(33) 
<1.17, p > 0.24). Some PD participants performed above the average score of the control 
group for the false belief task (n = 5), but most scores were clustered in the low score region 
with 15 out of 20 PD participants scoring below the average score of controls. When the 
analysis between PD and HC performance on the false belief task was re-run, removing the 2 
under 29% risk of conversion participants (one scored 11, the other 9), the result was similar, 
t(31) = 2.34, p = 0.03. The scores of the two under 29% risk score participants were close to 
Figure 8. Raw scores for Parkinson’s disease and healthy control participants in each of the four 
card sequencing tasks. Error bars show standard error of the mean.   
FB = False Belief; SS = Social Script, M = Mechanical, C = Complex Reasoning 






























the average ToM score of the PD group, they scored 9 (-1.34 SD below the mean of HC) and 
11 (-0.95 SD below mean). 
3.6 The Autobiographical Memory Interview (AMI) 
3.6.1  Autobiographical (episodic) Memory 
Figure 9 shows the mean autobiographical incident (episodic) memory scores for the two 
groups across the 3 AMI time periods. The PD group scored lower than the HC group across 
the three time points (main effect, F(1,33) = 9.04, p = 0.01; ES (d) = 1.03 (0.3 to 1.7)). The 
main effect for group remained when controlling for age, sex and education (F(1, 30) = 7.73, 
p = 0.01) and when controlling for anxiety and depression (F(3,29) = 3.40, p = 0.03). 
Although the group difference was greater for childhood than for young adult and recent 
autobiographical memory, there was no significant group x time period interaction (F(2,66) = 
2.48, p = .09). However Newman-Keuls post hoc tests suggested a significant difference 









Figure 9. Mean autobiographical memory scores for Parkinson’s disease and healthy 




When the analysis between PD and HC for autobiographical memory recall was re-run 
without the 2 under 29% risk of conversion participants, the results were similar, F(1,31) = 
6.83, p =0.01. The two under 29% risk score participants scored 4 (-3 SD below mean of HC) 
and 5 (-3 SD below mean) for the childhood period, 6 (-0.8 SD below mean) and 5 (-1.6 SD 
below mean) for the young adult period and 5 (-2.98 SD below mean) and 8 (0.21 SD above 
mean) for the recent period. These scores can be seen in Figure 10 which shows the 
distribution of raw scores for incident (episodic) autobiographical memory. Apart from the 
score of 8, these scores are below average for the HC and PD participants’ autobiographical 
memory recall. Overall PD scores were much more dispersed for the childhood period.  
Figure 10. Distribution of autobiographical incident (episodic) memory scores for PD and HC for each time 


















































3.6.2 Personal Semantic Memory 
Figure 11 shows the mean personal semantic memory scores for the two groups across the 
three AMI time periods. There was no significant difference between the personal semantic 
recall of PD or HC groups (F(1,33) = 1.49, p=.23; ES (d) = 0.42 (-0.3 to 1.1)). There was a 
significant main effect of time (F(2,66) = 16.91, p<.001). Both PD and HC groups had poorer 
recall for the childhood period but achieved an almost perfect score for the recent period. 
However when controlling for age, sex and education this difference across time points was 
no longer significant, F(2,60) = 1.52, p =.22, the same was found when controlling for 












Figure 11. Mean personal semantic memory scores of Parkinson’s disease and healthy 
controls at each time point during the Autobiographical Memory Interview. 
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When the analysis between PD and HC for semantic memory recall was re-run without the 2 
under 29% risk of conversion participants, the main effect of group remained non-significant 
(F(1,31) = 1.94, p=.17) and the effect of time was similar (F(2, 62) = 16.35, p < 0.001). The 
two under 29% risk score participants scored 19 (0.23 SD above mean of HC) and 18 (-0.17 
SD below mean) for the childhood period, 19.5 (0.29 SD above mean) and 21 (1.30 SD above 
mean) for the young adult period and 21 (0.79 SD above mean) and 19.5 (-1.45 SD below 
mean) for the recent period. These scores can be seen in Figure 12 which shows the 
distribution of raw scores for personal semantic memory. The scores of the two under 29% 
risk score participants are above the average of the PD participant group for all 3 time 
periods. Overall Figure 12 shows both PD and HC are clustered together apart from a few 
low scores in each group. 
 
























3.7 Correlations between the cognitive decline risk score and other 
measures 
Table 7 shows correlations between test scores of the PD participants only (n= 20) and the 
risk score (percentage likelihood of future progression to PD-MCI or PDD). Only two tests 
were significantly correlated with the risk score: the BVMT delayed recall and the SDMT. 
Table 7 shows a moderate negative correlation between the BVMT delayed recall and the 
progression score, r = -0.47. Generally as BVMT delayed recall scores decrease, the risk 
score increases. There was a moderate negative correlation between the SDMT and the risk 
score, r = -0.56. Generally as SDMT scores decrease, the risk score increases. Table 7 shows 
correlations between the scores of two other tests: BVMT delayed recall with BVMT total 
recall, and BVMT delayed recall with the SDMT. As expected there was a strong positive 
correlation between the BVMT total recall and the BVMT delayed recall, r = 0.80. There was 
also a moderate positive correlation between the SDMT and delayed recall, r = 0.60. There 
was also a modest but non-significant correlation between BVMT delayed recall and false 










Correlations between test scores of the Parkinson’s group and the percentage decline risk 
score 
 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 11. 
1. Risk score 1.00           
2. False belief 
-0.00 1.00          
3. AMI 
incidents 
0.10 -0.09 1.00         
4. AMI 
semantic -0.14 -0.14 0.32 1.00        
5. BVMT total 
recall 
-0.11 0.37 -0.42 -0.18 1.00       
6. BVMT 
delayed recall 
-0.47* 0.30 -0.36 -0.09 0.80* 1.00      
7. SDMT  
-0.56* 0.08 0.04 0.28 0.36 
0.60
* 
1.00     
8. SYDBAT 
Naming 
-0.31 0.18 -0.01 0.07 -0.15 -0.21 -0.20 1.00    
9. SYDBAT 
Repetition** 
        1.00   
10. SYDBAT 
Word Comp 




-0.12 0.08 0.25 -0.09 -0.28 -0.28 -0.32 0.26  0.42 1.00 
Note *p<.05 
**no correlation because max SYDBAT repetition scores 
Abbreviations: AMI = Autobiographical Memory Interview; BVMT = Brief Visuospatial Memory Test; 
SYDBAT = The Sydney Language Battery 
 
3.8 Correlations between clinical Parkinson’s disease measures and key test 
scores 
Table 8 shows the correlations between key Parkinson’s disease stage measures and key 
testing measures form the current study (n=20). There was a moderate significant correlation 
between the UPDRS motor and Hoehn and Yahr stage (0.66). There was a moderate 
significant correlation between the DRS-2 and BVMT delayed recall (0.66). There was a 
moderate correlation between HADS Anxiety and HADS Depression (0.56) and between 
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HADS Anxiety and AMI semantic recall (-0.56). There was also a correlation between 
HADS Depression and AMI semantic recall (-0.49). 
There were modest but non-significant correlations between the risk score and DRS-2 
(-0.41), between the AMI incident recall and the DRS-2 (-0.39), between the ADAS-Cog and 
DRS-2 (-0.33), between false belief and the ADAS-Cog (-0.33), between AMI incident recall 

















Correlations between Parkinson’s disease participant motor, cognition and disease stage 














UPDRS motor 1.00        
DRS-2 
-0.05 1.00       
H & Y 0.66 0.44 1.00      
ADAS-Cog 
-0.10 -0.33 0.02 1.00     
ADL-IS** 
0.25 -0.35 -0.02 -0.19 1.00    
HADS Anxiety 
-0.09 -0.23 -0.08 -0.13 -0.15 1.00   
HADS Depression 
-0.01 -0.14 0.02 -0.08 0.01 0.56 1.00  
Disease Duration 0.04 0.26 0.26 0.01 0.29 -0.35 0.19 1.00 
AMI incidents 
0.17 -0.39 -0.07 0.34 0.07 -0.29 -0.28 -0.24 
AMI semantic 0.12 0.02 -0.09 0.05 0.23 -0.56 -0.49 0.33 
False belief 
0.17 -0.06 0.00 -0.33 0.17 0.01 0.19 -0.19 
Risk score 0.02 -0.41 0.02 0.06 0.03 0.15 0.27 -0.18 
BVMT total recall 0.13 0.37 0.28 -0.02 -0.12 0.00 0.18 0.01 
BVMT delayed recall 0.12 0.66 0.37 -0.10 -0.26 -0.08 -0.08 0.02 
Note *p<.05 
** n = 17 for this measure (1 participants data was missing for an unknown reason and 2 participants’ data could not be 
collected) 
Abbreviations: ADAS-Cog = Alzheimer’s Dementia Assessment Scale-Cognitive; ADL-IS = Activities of Daily Living- 
International Scale; AMI = Autobiographical Memory Interview; BVMT = Brief Visuospatial Memory Test; DRS-2 
(AESS) =  Dementia Rating Scale (age and education scales score); H & Y = Hoehn and Yahr stage; HADS = Hospital 
Anxiety and Depression Scale; UPDRS = Unified Parkinson’s Disease Rating Scale 
54 
 
3.9 Correlations between test scores across both PD and HC group 
Table 9 shows the correlations between different overall test scores using the scores of both 
PD and HC (n=35). Five significant correlations were found between test scores. A moderate 
positive relationship was found between false belief (ToM) and BVMT total recall, r = 0.46, 
and a moderate positive relationship between false belief (ToM) and BVMT delayed recall, r 
= 0.41. Generally, as BVMT total and delayed recall increase, performance on the ToM task 
also increases. However, when BVMT total recall and delayed recall were correlated with 
AMI incidents, this significance dropped out. As expected there was a strong positive 
relationship between BVMT delayed recall and BVMT total recall, r = 0.87. There was a 
moderate positive relationship between the SDMT and BVMT total recall (r = 0.51) and 
BVMT delayed recall (r = 0.65). Generally as SDMT performance increases, so too does 
BVMT total and delayed recall. Significant relationships were not found between 
autobiographical memory scores and semantic memory scores (r = .20) or between false 










Table 9.  
Correlations between tests including scores of Parkinson’s disease participants and healthy 
controls  
 1. 2. 3. 4. 5. 6. 7. 8. 9. 10. 
1. False belief 1.00          
2. AMI incidents 0.18 1.00         
3. AMI semantic 
-0.20 0.20 1.00        
4. BVMT total 
recall 
0.46* 0.08 0.10 1.00       
5. BVMT delayed 
recall 
0.41* 0.08 0.10 0.87* 1.00      
6. SDMT  0.21 0.20 0.30 0.51* 0.65* 1.00     
7. SYDBAT 
Naming 
0.03 0.02 0.07 0.14 0.01 0.04 1.00    
8. SYDBAT 
Repetition 
       1.00   
9. SYDBAT Word 
Comp 




0.00 0.24 0.06 0.04 0.00 -0.01 0.30  0.18 1.00 
Note *p<.05 
**no correlation because max SYDBAT repetition scores 
Abbreviations: AMI = Autobiographical Memory Interview; BVMT = Brief Visuospatial Memory 








4.1 Main findings 
The current study was the first to examine both personal episodic and personal semantic 
lifetime memories in PD. Moreover all but two participants were identified as pre-MCI PD, a 
novel group not yet defined in the PD literature that is at risk of cognitive decline over the 
next four years. There was a mild but selective deficit in autobiographical (episodic) 
memories in this group of patients whereas personal semantic memory was unimpaired. 
There was a suggestion that the poorer autobiographical recall in the PD group was greatest 
for the childhood period but they were generally impaired across all three lifetime periods 
examined. Secondly, a cognitive ToM task also revealed a deficit in this group of PD 
participants, shown by poorer performance in the false belief card sequencing task. However, 
the PD and control groups performed equally on the other sequencing (non-ToM) tasks, 
suggesting a specific ToM deficit rather than a more general cognitive problem.  
Contrary to the hypothesis, there was no association between autobiographical 
memory and the ToM in this group of PD participants. There was also no association between 
the cognitive decline risk score, which was based on age of an individual plus the four 
cognitive screening tests, and either autobiographical memory or ToM. However, these latter 
negative findings may be because this PD group has relatively normal cognition (pre-MCI) 
and an association may exist in a more cognitively impaired group of PD participants. 
Conversely, the BVMT delayed recall did show a moderate correlation with the cognitive 
decline risk score, suggesting that the BVMT may be a useful measure to test memory 
deficits in individuals with early stage PD and thus could be added to future models of risk of 
cognitive decline. The quality of the results found in the current study is superior to previous 
research as the cognitive status of the PD participant group was thoroughly characterised. The 
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relevant prior research often used the MMSE or a few neuropsychological tests and did not 
fully characterise their patients other than specifying them as PDD or PD without dementia.  
The novelty of the current research findings contributes to a growing body of literature that is 
helping researchers and practitioners to understand the nature of early PD.  
4.2 Comparison of main findings with prior research 
The PD group was significantly impaired at recalling autobiographical memories across the 
three lifetime periods compared to controls. This was consistent with previous research of 
autobiographical episodic memory in PD (Sagar et al., 1988; Smith et al., 2010; Souchay & 
Smith, 2013). However the pattern of temporal gradient of the episodic memory recall was 
contrary to what the prior PD literature on episodic autobiographical memory might suggest. 
PD participants on average recalled less autobiographical memories (incidents) for the 
childhood period than for the young adult or recent period. The three articles that investigated 
autobiographical memory in PD (discussed in the introduction) all found recent 
autobiographical events were recalled more poorly than remote autobiographical events 
(Sagar et al., 1988; Smith et al., 2010; Souchay & Smith, 2013). This pattern of episodic 
memory recall is also evident in AD, including mild AD (Kopelman et al., 1989; Levy, 
1988). The pattern of episodic memory recall of the PD group in the current study is more 
similar to the controls in previous literature. For example, Kopelman et al. (1989) found that 
control participants recalled more detailed recent personal episodic memories on the AMI, 
compared to less detailed childhood episodic memories. However, the controls in the current 
study actually achieved better recall for their childhood memories compared to the other time 
periods. The raw data for autobiographical incident recall (Figure 10), reveals that a small 
group of 5 PD participants skewed the average with poorer recall for the childhood period 
than for the other time periods. Some participants commented that recalling details from their 
childhood was especially difficult. 
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The amygdala, hippocampus and right inferior frontal gyrus show functional 
connectivity during episodic memory recall (Greenberg et al., 2005). These brain regions 
often show atrophy of functional loss in PD. The non-MCI PD participants in the current 
study showed only a mild deficit in episodic memory recall, so the connectivity across these 
regions may be disrupted to a lesser degree than in later stage PD participants, such as PD-
MCI, who show more significant episodic memory impairments. MRI images of the PD 
participants in this study were taken as part of the broader study at the NZBRI, so future 
research could analyse the connectivity in these areas and correlate it with autobiographical 
memory and ToM performance in these patients. In addition, PD-MCI participants could be 
tested, and included in analyses to determine comparisons across different levels of cognitive 
status.   
Unlike personal episodic memories, both PD and HC groups performed equally well 
at personal semantic memory recall, with high scores across all time periods. Recall was 
generally more detailed for recent memories and least detailed for childhood memories in 
both groups. Examination of the raw scores for personal semantic memory (Figure 12) shows 
that both PD and HC participants are clustered near the max score of 21 for all three time 
periods, especially the recent period. The scores for the childhood period were the most 
varied. Only a couple of scores fell below the cluster in the childhood period, with one 
control scoring a low score of 11 and two PD scoring 12.5 and 13.5, and in the young adult 
period only one PD participant scored below the cluster with a score of 13. There was no 
correlation between the recall of personal episodic memory and personal semantic memory 
scores, providing additional evidence of the independence of these two measures of 
autobiographical memory recall. The similar performance of both PD and controls at personal 
semantic memory recall is similar to the results of Smith, Souchay & Conway (2010), who 
also found no group difference at this measure. However, Smith, Souchay and Conway 
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(2010) reported the opposite temporal gradient, with fewer names recalled in the recent time 
periods compared to early time periods for both PD and HC (Smith, Souchay & Conway, 
2010). Their results, however, came from a different autobiographical memory test, the 
‘autobiographical fluency task’, which could account for differences in the pattern of 
findings.   
The same pattern of results was found for the different card sequencing tasks in the 
current study as was reported by Mengelberg and Siegert (2003). That is, PD participants 
scored significantly lower on the false belief category, with mean values almost identical to 
this previous report, but there were no significant difference between groups on the three 
control categories, suggesting a specific ToM deficit. The only difference between the results 
of the current study and that of Mengelberg and Siegert (2003) was performance on the 
capture (complex reasoning) card category. This was the most difficult of the control card 
tasks. On the capture task, Mengelberg and Seigert’s controls scored on average about 12.5 
out of 24, and their PD group scored about 11.5 out of 24. The controls in the current study 
scored on average 16.07, and the PD scored on average 14.35. This suggests that the PD 
participants in the current study had better complex reasoning, yet were still impaired to the 
same level at ToM.  
One key hypothesis was that there would be a correlation between the episodic 
measure of the AMI and ToM because these tasks are both associated with blood oxygen 
level-dependent (BOLD) functional activity in DMN subsystems. The current study found, 
however, no significant relationship between personal episodic autobiographical memory and 
ToM. While there is a modest cognitive ToM impairment, there was a less pronounced deficit 
in episodic autobiographical memory. There was reasonable variance in both episodic 
memory and ToM scores, so the lack of correlation cannot be attributed to the cognitively 
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unimpaired status of the PD group. These results suggest that there may be dissociation 
between the regions that underlie these two tasks. The default mode network is frequently 
activated by both autobiographical memory and ToM tasks (Andrews-Hanna, 2010), but each 
task is correlated to a different subsystem within the DMN. Dissociation of these subsystems 
could explain this lack of correlation. The dorso medial prefrontal cortex (dMPFC) is 
associated with ToM functioning, whereas the medial temporal lobe subsystem is thought to 
underlie episodic/autobiographical memory. These two regions may degenerate or become 
dysfunctional at different times during the PD disease process. It is possible that the dMPFC 
is associated more specifically to affective ToM than to cognitive ToM. This could explain 
the lack of correlation between autobiographical memory and cognitive ToM. Previous 
research has suggested that affective ToM is only impaired in PD patients during the later 
stages of the disease (Poletti et al., 2011), and the current study shows that autobiographical 
memory may show more significant impairment in PD participants who are more cognitively 
impaired. It would of interest in future research to see if there is a correlation between 
autobiographical memory and affective ToM, both of which may be more significantly 
impaired in later stage PD.  
It was hypothesised that there might be a relationship between the cognitive decline 
risk score of the PD participants and their AMI and ToM performance, but this was not 
found. Higher risk scores did not predict poorer performance on the AMI or ToM. There was 
a good range of scores for autobiographical recall and ToM performance across participants 
so lack of variation in scores does not explain the failure to observe this association. Some 
PD participants who performed poorly in the screening assessment (which formed the risk 
score) performed well on the ToM task, and some participants who performed poorly in the 
ToM task performed well in the screening assessment. One possibility to explain this lack of 
correlation could be that the risk score is predicting a decline in areas that are not associated 
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with autobiographical memory or ToM. If the subsystems that underlie autobiographical 
memory and ToM are distinct enough in their function from areas that underlie the screening 
tests, then these areas may degenerate at a different rate. Two of the cognitive screening tests 
that are part of the risk score measure executive function (Stroop-interference, Trails B),  
another measures attention, working memory and processing (TEA Map Search) and the 
MoCA provides a brief global function measure. As per Mengelberg and Siegert (2003), 
ToM performance was unrelated to executive function deficits. The ToM functions seem 
independent to those other cognitive domains. Given the discussion above about the 
dissociation between cognitive and affective ToM, future research should investigate the 
correlation between affective ToM and the risk score, as this measure could contribute to 
indicative risk of future decline. 
Results of the initial screening tests showed that although there was a significant 
difference between the two groups on all key measures (MoCA, Stroop-interference, Trails 
B, and the TEA Map Search; also Trails A), performance of PD and HC groups on Stroop-
colour and stroop-word was similar. Neither motor symptoms, based on the UPDRS, nor 
neuropsychiatric symptoms, based on the HADS, had any impact on the scores of the PD 
participants on the key measures in the current study (episodic AMI, ToM card sequencing 
task and BVMT). However anxiety and depression did show a significant correlation with 
AMI semantic recall scores, but not with episodic memory recall, which was the important 
measure in this study. There was also no significant difference on the four language measures 
across PD and HC, and both groups which scored highly on those measures, suggesting that 
basic language functions are not impaired in early PD.  
An unexpected finding was that the BVMT delayed recall score showed a greater 
effect size between performance of the PD and HC group than any of the other measures used 
in the initial screening test. This was surprising because prior work at the NZBRI using other 
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memory tests (Rey-Osterrieth Complex Figure Copy and CVLT recall) found these measures 
relatively intact in non-MCI patients with PD. There was also a significant relationship 
between the cognitive decline risk score and poor BVMT delayed recall score in the patient 
group in the current study. Together these findings suggest that the BVMT delayed recall 
may be a good predictor of early cognitive change. This measure may be a more useful 
addition to screening measures used in this particular participant group of PD patients (pre-
MCI). A moderate correlation between the BVMT delayed recall score and the risk score, 
rather than a high correlation, is a useful finding as it shows that the BVMT could add more 
value to the risk score; a high correlation would show that the risk score and the BVMT 
delayed recall essentially overlap and the BVMT does not add new information. The BVMT 
total and delayed recall was correlated with the ToM task, but not with the AMI (episodic) 
incidents. This dissociation between the two episodic memory tasks, one for visuospatial 
recent memory and one for past personal incidents, suggests that these two measures have a 
different neural basis.  
A strength of this research is the better characterisation of the participant group 
compared to the 3 other studies that have investigated autobiographical memory in PD. Two 
of the previous studies (Smith et al., 2010; Souchay and Smith 2013) used the MMSE as their 
main cognitive measure which has been shown to be less sensitive than even the MoCA for 
PD (Dalrymple-Alford et al., 2010). The third study used only the Blessed Dementia Scale, 
another general cognitive measure (Sagar et al., 1988). A broader range of tests is needed to 
assess the cognition of PD patients (Litvan et al., 2012), a prerequisite which this study 
satisfies. It is difficult to compare results between studies that have poorly defined participant 
groups. Participants at different stages of PD can have different cognitive performance on 
tasks, so without well-defined participant groups the results are less meaningful. Research is 
increasingly focussing on determining cognitive change and following progression, thus 
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careful attention needs to be paid to participant characterisation at different stages in the 
disease course to build a reliable body of literature.   
4.3 Limitations 
Although the sample size in the current study is larger than most of the studies discussed in 
the introduction, it is still relatively small. Small sample sizes place limits on the power of the 
study and potential accuracy of the ensuing results. It is possible that the correlations between 
measures found in this study may not be a true reflection of the relationships due to this small 
sample size. A larger sample size would have also allowed for more detailed analyses of 
poorer performers within each task. In addition, having only 2 participants from the under 
29% risk score category made it impossible to compare fully their results with that provided 
by patients in the over 29% risk score group. A larger sample of the under 29% participants 
would have been valuable to compare between PD participants with lower and higher risk 
scores, but this was not possible in the time available.   
Results of this study would have been strengthened with a comparison to a PD-MCI 
group. This would have given a clearer understanding of how autobiographical memory and 
ToM are affected in more significant cognitive impairment. There was also lack of any 
imaging in the current study which meant correlations between task performance and 
associated brain regions could not be analysed. Brain imaging would have been useful 
especially to analyse the dissociation between areas associated with autobiographical memory 
and ToM, and to see if imaging was able to differentiate between lower and higher cognitive 
decline risk scores.  
Although the current study did examine the relationship between motor severity and 
test scores, there was no analysis of the motor sub-types of PD, such as non-tremor dominant 
(rigid-akinetic) subtype and tremor subtype. Patients with the tremor dominant motor sub-
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type tend to have shorter disease duration, less severe motor symptoms and less cognitive 
impairment (Burn et al., 2012). Future research should differentiate between these two 
subtypes to investigate a difference in AMI and ToM test performance and use imaging to 
investigate structure and functioning in the brain.  
4.4 Future Directions 
Future research should test the correlation between the cognitive decline risk score and the 
AMI and ToM with PD-MCI participants to see if a relationship between these measures 
eventuates in a more severely impaired participant group. The relationship between these 
measures should be tested with a larger participant group and should include not only PD-
MCI but lower risk pre-MCI participants (under 29%) as well as higher risk pre-MCI 
participants (over 29%), together with PDD participants. This would provide information for 
a range of participants across disease stages, allowing for a comparison between these groups 
and analysis of significant changes at each stage of PD. As mentioned earlier, MRI images 
were taken for the participants in this study as part of a broader study at the NZBRI. These 
images should be analysed in future research to see if there is any correlation between 
performance on autobiographical memory and ToM with degeneration or poor function in 
associated brain areas. For example, analyses of MRI images may show a relationship 
between the risk score and cortical thinning, as previous research has shown that cortical 
thinning is evident prior to overt cognitive changes (Mak et al., 2015). 
The current study also suggests that the BVMT should be considered as a screening 
measure for participants in future research and added to predictive progression models like 
the risk score used in this study. The BVMT is sensitive to mild impairment that other tests 





The aim of the current study was to examine autobiographical memory and ToM in a well 
characterised PD patient group in whom cognition was relatively unimpaired (non-MCI) but 
who were showing risk of future decline. This study used the AMI for the first time with a 
PD participant group and found significant impairments in personal episodic memory 
compared to HC participants. There was also a significant impairment of PD participants on 
the ToM task compared to controls. Although it was hypothesised that there would be a 
correlation between autobiographical memory and ToM due to an overlapping of associated 
brain areas, this was not found. There was also no correlation between these measures and the 
cognitive decline risk score, suggesting the AMI and card sequencing task are not useful as 
predictors of future cognitive decline. However, the BVMT delayed was associated with the 
risk score and surprisingly had a larger effect size between groups than any other measure in 
the screening test. The BVMT may be useful to add to predictive models of future cognitive 
decline and may detect cognitive change in the early stages of cognitive decline in PD. The 
results of this study contribute to a growing body of literature on the non-MCI PD patients 
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Prac 1      Prac 1 
Prac 2      Prac 2 
3 OGYB   BYGO  3 
9 YGBO   BYGO  9 
17 OBYG   GYOB  17 
12 GYOB   GYBO  12 
18 YBOG   BGOY  18 
10 YOBG   GYBO  10 
5 YGBO   YOBG  5 
14 OYBG   YBOG  14 
8 YBOG   GBYO  8 
15 BGYO   YOGB  15 
7 GOYB   OBYG  7 
11 BGYO   YBGO  11 
4 BGOY   OBYG  4 
13 GBOY   OBYG or 
OBGY 
 13 
16 GYOB   BOYG  16 






Appendix B.  
Neuropsychological 
Domain 
Neuropsychological Test PD mean (SD) 
(n = 20) 
Test of means 





Digits Forward and Backward 
Digit ordering 










p = 0.04 
p = 0.02 
p = 0.00 
p = 0.13 
p = 0.73 
p = 0.03 












p = 0.00 
p = 0.00 
p = 0.00 
p = 0.75 
p = 0.02 
p = 0.88 
Visuoperceptual/Visu
ospatial 








p = 0.43 
p = 0.05 
p = 0.01 
p = 0.00 
Learning and Memory CVLT Free recall 
CVLT Short delay 








p = 0.37 
p = 0.29 
p = 0.68 
p = 0.94 
p = 0.57 
Language Boston Naming 





p = 0.00 
p = 0.30 
p = 0.69 
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15% 27 1.33 1.21 1.58 0.33 19 9 1.32 27 30 29 25 9 17 58.5 
24% 30 1.33 1.38 1.61 0.00 21 10 1.66 24 30 29 28 11 16 59.5 
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